Hubei Guangji Pharmaceutical Co Ltd
SZSE:000952
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Hubei Guangji Pharmaceutical Co Ltd
SZSE:000952
|
CN |
|
Taekyung BK Co Ltd
KRX:014580
|
KR |
|
Old Mutual Ltd
LSE:OMU
|
ZA |
|
U
|
Uniparts India Ltd
NSE:UNIPARTS
|
IN |
|
K
|
Khemani Distributors & Marketing Ltd
BSE:539788
|
IN |
|
VerifyMe Inc
NASDAQ:VRME
|
US |
|
A
|
Anchorstone Holdings Ltd
HKEX:1592
|
HK |
|
D
|
Deckers Outdoor Corp
SWB:DO2
|
US |
|
Ramco Cements Limited
NSE:RAMCOCEM
|
IN |
|
K
|
Kretto Syscon Ltd
BSE:531328
|
IN |
|
Genting Malaysia Bhd
OTC:GMALF
|
MY |
|
Axiscades Technologies Ltd
NSE:AXISCADES
|
IN |
Dividends
Dividend Yield
Hubei Guangji Pharmaceutical Co Ltd
| Current Yield | |
| Min Yield | |
| Max Yield | |
| Average Yield | |
| Median Yield |
Dividend Per Share
Hubei Guangji Pharmaceutical Co Ltd
Hubei Guangji Pharmaceutical Co Ltd have
decreased
by 0%.
Payout Ratio
Hubei Guangji Pharmaceutical Co Ltd
Peers Comparison
Dividends
Shareholder Yield
Current shareholder yield for Hubei Guangji Pharmaceutical Co Ltd is
hidden
.
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
Price
Hubei Guangji Pharmaceutical Co Ltd
| Average Annual Return | -4.08% |
| Standard Deviation of Annual Returns | 16.27% |
| Max Drawdown | -51% |
| Market Capitalization | 2.4B CNY |
| Shares Outstanding | 346 750 000 |
| Percentage of Shares Shorted |
N/A
|
Return Decomposition
Main factors of price return
Stock Splits
Hubei Guangji Pharmaceutical Co Ltd's latest stock split occurred on May 29, 2020
The company executed a 1-for-1 stock split, meaning that for every share held, investors received 1 new share.
Before the split, Hubei Guangji Pharmaceutical Co Ltd traded at 8.6583 per share. Afterward, the share price was about 8.4815.
The adjusted shares began trading on May 29, 2020. This was Hubei Guangji Pharmaceutical Co Ltd's 2nd stock split, following the previous one in Jul 24, 2006.
